The Newsroom
Item 1 of 3
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
Item 2 of 3
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
Recent Stories at AdventHealthMD
-
-
Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery in Cervical Cancers Size 2-4 cm: Emerging Data and Future Perspectives
-
Isolated Vulvar Langerhans Cell Histiocytosis
-
AdventHealth Physician Research Highlights Need for Genetic Testing to Target Non-Small-Cell Lung Cancer Treatment
-
Comparison of Myeloablative versus Reduced-intensity Conditioning Regimens in Allogeneic Stem Cell Transplantation Recipients with Acute Myelogenous Leukemia with Measurable Residual Disease-Negative Disease at the Time of Transplantation: A Retrospective
-
AdventHealth First in Central Florida to Offer Movement Disorder Patients Access to NeuroSphere Virtual Clinic for Remote Adjustment of Neurostimulation Devices